¼¼°èÀÇ ¸ÞŸ°Ô³ð ½ÃÄö½Ì ½ÃÀå º¸°í¼­(2024³â)
Metagenomic Sequencing Global Market Report 2024
»óǰÄÚµå : 1527063
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 6,977,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,465,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,954,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸ÞŸ°Ô³ð ½ÃÄö½Ì ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È ¿¬Æò±Õ 17.2%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇϸç 2028³â±îÁö 40¾ï 2,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ÄÄÇ»ÆÃ ºñ¿ëÀÇ °¨¼Ò, »õ·Î¿î »ýü ºÐÀÚ ¹ß°ß¿¡ ´ëÇÑ °ü½É Áõ°¡, °í¼º´É ½ÃÄö½Ì ±â¼ú äÅà Ȯ´ë, °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¹× Áúº´ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä, °¨¿°¼º ÁúȯÀÇ ±Þ°ÝÇÑ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ ½Ã±âÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Çõ½Å ±â¼ú, ¸ÞŸÀ¯ÀüüÇп¡¼­ ÷´Ü À¯Àüü ±â¼ú Ȱ¿ë, ¿¬±¸°³¹ß ÀÚ±Ý Áõ°¡, ½ÃÄö½Ì ±â¼úÀÇ ¹ßÀü, NGS µ¥ÀÌÅÍ ºÐ¼®¿¡¼­ ºòµ¥ÀÌÅÍ È°¿ë µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

°¨¿°¼º Áúȯ Áõ°¡´Â ¸ÞŸ°Ô³ð ½ÃÄö½Ì ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Áúº´Àº ¹ÚÅ׸®¾Æ, ¹ÙÀÌ·¯½º, ±â»ýÃæ, °õÆÎÀÌ¿Í °°Àº º´¿ø¼º ¹Ì»ý¹°¿¡ ÀÇÇØ ¹ß»ýÇÏ¸ç »ç¶÷ °£ Á÷Á¢ ¶Ç´Â °£Á¢ÀûÀ¸·Î Àü¿°µÇ¸ç, HIV/AIDS, ¾Ï Ä¡·á, ÀÚ°¡¸é¿ª Áúȯ°ú °°Àº ¸é¿ª ü°è¸¦ ¾àÈ­½ÃŰ´Â Ä¡·á´Â °¨¿°¿¡ ´ëÇÑ °¨¼ö¼ºÀ» Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ¸ÞŸ°Ô³ð ½ÃÄö½ÌÀº º´¿øÃ¼ÀÇ ´Ù¾ç¼º, °¨¿° ¿ªÇÐ, Ç×±ÕÁ¦ ³»¼º, ¹ßº´ °¨½Ã µî¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÏ´Â °­·ÂÇÑ °¨¿°º´ ¿¬±¸ ¹æ¹ýÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù UNAIDS¿¡ µû¸£¸é Àü ¼¼°è HIV °¨¿°ÀÚ´Â 2020³â ´ëºñ 3.17% Áõ°¡ÇÑ 3,900¸¸ ¸íÀ» ³Ñ¾î¼³ °ÍÀ̸ç, 2022³â¿¡´Â ¾à 130¸¸ ¸íÀÌ »õ·Î °¨¿°µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ´Â 2021-2022³â »çÀÌ ¹Ì±¹ ³» °áÇ٠ȯÀÚ ¼ö°¡ 5.9% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ °¨¿°¼º ÁúȯÀÇ ±ÞÁõÀº ¸ÞŸ°Ô³ð ½ÃÄö½Ì ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¸ÞŸ°Ô³ð ½ÃÄö½Ì ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº Á¤È®µµ, 󸮷®, ºñ¿ë È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ ½ÃÄö½Ì ¼­ºñ½º¸¦ °­È­ÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ½ÃÄö½Ì ¼­ºñ½º¿¡´Â ´õ ±ä DNA Á¶°¢À» ½ÃÄö½ÌÇÒ ¼ö ÀÖ´Â °í±Þ À¯Àüü ±â¼úÀÌ Æ÷ÇԵǾî ÀÖ¾î, ±âÁ¸ ¼ô¸®µå(short read) ¹æ½Ä¿¡ ºñÇØ À¯ÀüÀÚ ±¸Á¶¸¦ º¸´Ù »ó¼¼ÇÏ°Ô ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Clinical Microbiomics A/S´Â 2024³â 4¿ù 16S, ITS, 18S rRNA, ¸ÂÃãÇü À¯ÀüÀÚ ½ÃÄö½Ì, Á¾ÇÕÀûÀÎ À¯ÀüüÇÐ ¹× ¸ÞŸÀ¯ÀüüÀ» Æ÷ÇÔÇÑ °í±Þ ·Õ¸®µå ½ÃÄö½Ì ¼­ºñ½º¸¦ µµÀÔÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ¹Ì»ý¹° ºÐ¼®¿¡ ÀÖ¾î µ¶º¸ÀûÀÎ ÇØ»óµµ¿Í ǰÁúÀ» Á¦°øÇϸç, ¹Ì»ý¹° ±ºÁý¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÅëÂû·Â°ú °íǰÁú ¸ÞŸÀ¯Àüü Áý´Ü À¯ÀüüÀ» ½±°Ô »ý¼ºÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå °æÀï º¥Ä¡¸¶Å·

Á¦33Àå °æÀï ´ë½Ãº¸µå

Á¦34Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦35Àå ÇâÈÄ Àü¸Á°ú ÀáÀçÀûÀÎ ºÐ¼®

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Metagenomic sequencing is a technique used to analyze the genetic material from an entire community of microorganisms in a specific environment without culturing individual species. This method involves extracting DNA directly from environmental samples, such as soil, water, or the human gut, and then sequencing it using high-throughput sequencing technologies.

The main products and services in the metagenomic sequencing market include reagents and consumables, instruments, sequencing services, and analysis and data interpretation solutions. Reagents and consumables encompass the chemical substances, kits, and disposable items used in laboratory experiments and procedures. The various technologies include 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de novo assembly, and metatranscriptomics. These technologies are used in various applications such as clinical diagnostics, environmental remediation, gut microbe characterization, drug discovery, biofuel production, agriculture, and other fields.

The metagenomic sequencing market research report is one of a series of new reports from The Business Research Company that provides metagenomic sequencing market statistics, including metagenomic sequencing industry global market size, regional shares, competitors with a metagenomic sequencing market share, detailed metagenomic sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the metagenomic sequencing industry. This metagenomic sequencing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The metagenomic sequencing market size has grown rapidly in recent years. It will grow from $1.82 billion in 2023 to $2.13 billion in 2024 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to the increasing involvement of governments, a growing number of metagenome sequencing research projects, the expanding application of metagenomics in genomics and diagnostics research, the availability of research funding, and the development of Next-Generation Sequencing (NGS) data analysis tools.

The metagenomic sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.02 billion in 2028 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to decreasing computational costs, a growing focus on discovering novel biomolecules of interest, increasing adoption of high-throughput sequencing technologies, demand for personalized medicine and disease diagnosis, and a surge in the prevalence of infectious diseases. Major trends in this period include innovative technologies, the utilization of advanced genomic technologies in metagenomics, augmented R&D funding, advancements in sequencing technology, and the use of big data for NGS data analysis.

The increase in infectious diseases is expected to fuel the growth of the metagenomic sequencing market. These diseases, caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, can spread from person to person directly or indirectly. Conditions that compromise the immune system, such as HIV/AIDS, cancer treatments, and autoimmune disorders, can heighten susceptibility to infectious diseases. Metagenomic sequencing is a robust method for studying infectious diseases, offering insights into pathogen diversity, transmission dynamics, antimicrobial resistance, and outbreak surveillance. For example, as per UNAIDS in July 2023, global HIV cases surpassed 39 million, up 3.17% from 2020, with nearly 1.3 million new infections in 2022. Additionally, the Centers for Disease Control and Prevention reported a 5.9% rise in tuberculosis cases in the US from 2021 to 2022. This surge in infectious diseases is propelling growth in the metagenomic sequencing market.

Key players in the metagenomic sequencing market are concentrating on enhancing sequencing services to improve accuracy, throughput, and cost-effectiveness. Sequencing services involve advanced genomic technologies enabling the sequencing of longer DNA fragments, providing a more detailed view of genetic structures compared to traditional short-read methods. For instance, Clinical Microbiomics A/S introduced advanced long-read sequencing services in April 2024, including 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics. These services offer unparalleled resolution and quality in microbial analysis, facilitating detailed insights into microbial communities and the creation of high-quality metagenome-assembled genomes.

In January 2022, Illumina Inc. acquired IDbyDNA to bolster its infectious disease diagnostics and microbial genomics capabilities. This acquisition integrates IDbyDNA's expertise in metagenomic sequencing and bioinformatics with Illumina's portfolio of sequencing technologies and analytical solutions, enhancing their position in pathogen surveillance and infectious illness testing.

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the metagenomic sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metagenomic sequencing market includes revenues earned by entities by providing services such as sample preparation, sequencing, metagenomic profiling, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomic sequencing market also includes sales of sequencing platforms, bioinformatics software, DNA extraction kits, and sequencing reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metagenomic Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metagenomic sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for metagenomic sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metagenomic sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Scope

Table of Contents

1. Executive Summary

2. Metagenomic Sequencing Market Characteristics

3. Metagenomic Sequencing Market Trends And Strategies

4. Metagenomic Sequencing Market - Macro Economic Scenario

5. Global Metagenomic Sequencing Market Size and Growth

6. Metagenomic Sequencing Market Segmentation

7. Metagenomic Sequencing Market Regional And Country Analysis

8. Asia-Pacific Metagenomic Sequencing Market

9. China Metagenomic Sequencing Market

10. India Metagenomic Sequencing Market

11. Japan Metagenomic Sequencing Market

12. Australia Metagenomic Sequencing Market

13. Indonesia Metagenomic Sequencing Market

14. South Korea Metagenomic Sequencing Market

15. Western Europe Metagenomic Sequencing Market

16. UK Metagenomic Sequencing Market

17. Germany Metagenomic Sequencing Market

18. France Metagenomic Sequencing Market

19. Italy Metagenomic Sequencing Market

20. Spain Metagenomic Sequencing Market

21. Eastern Europe Metagenomic Sequencing Market

22. Russia Metagenomic Sequencing Market

23. North America Metagenomic Sequencing Market

24. USA Metagenomic Sequencing Market

25. Canada Metagenomic Sequencing Market

26. South America Metagenomic Sequencing Market

27. Brazil Metagenomic Sequencing Market

28. Middle East Metagenomic Sequencing Market

29. Africa Metagenomic Sequencing Market

30. Metagenomic Sequencing Market Competitive Landscape And Company Profiles

31. Metagenomic Sequencing Market Other Major And Innovative Companies

32. Global Metagenomic Sequencing Market Competitive Benchmarking

33. Global Metagenomic Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Metagenomic Sequencing Market

35. Metagenomic Sequencing Market Future Outlook and Potential Analysis

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â